U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07599696) titled 'Speech Amplification Devices for Parkinson Disease: Talker- and Technology-Driven Enhancements' on May 05.
Brief Summary: The proposed research aims to investigate the use of speech amplification devices as a potential treatment option for people with Parkinson's disease and related disorders who exhibit hypophonia, a voice disorder that affects over half of those with Parkinson's disease. By characterizing the acoustic and perceptual effects of speech amplification and identifying ways to optimize outcomes through talker- and device-specific enhancements, this project seeks to develop personalized, evidence-based treatment options f...